Back
Gilead Sciences Vs. Novo Nordisk AS Industry Stock Comparison
Buy
54
GILD
Gilead Sciences
Last Price:
$109.69
Seasonality Move:
6.94%
Sell
29
NVO
Novo Nordisk AS
Last Price:
$67.47
Seasonality Move:
0.86%
Buy
54
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
-
The current Gilead Sciences [GILD] share price is $112.09. The Score for GILD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $68.94. The Score for NVO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $112.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $68.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
GILD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 27.64 | Buy |
Relative Strength Index (14 RSI): | 54.8 | Buy |
Chaikin Money Flow: | 5900602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (108.11 - 112.53) | Buy |
Bollinger Bands (100): | (104.08 - 112.82) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.61 | Sell |
Relative Strength Index (14 RSI): | 44.56 | Sell |
Chaikin Money Flow: | -843344 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (68.2 - 76.4) | Sell |
Bollinger Bands (100): | (63.87 - 80.19) | Sell |
GILD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.95 | Buy |
20-day SMA: | 110.06 | Buy |
50-day SMA: | 107.59 | Buy |
200-day SMA: | 99.88 | Buy |
8-day EMA: | 80.13 | Buy |
20-day EMA: | 44.13 | Buy |
50-day EMA: | 20.32 | Buy |
200-day EMA: | 5.47 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 69.57 | Sell |
20-day SMA: | 70.92 | Sell |
50-day SMA: | 70.23 | Sell |
200-day SMA: | 86.68 | Sell |
8-day EMA: | 69.58 | Sell |
20-day EMA: | 70.36 | Sell |
50-day EMA: | 70.82 | Sell |
200-day EMA: | 84.57 | Sell |
Gilead Sciences Earnings Growth & GILD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.57 per share, and an increase next year of $0.53 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.10 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Gilead Sciences Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |